H. Sauer

Autoantibodies against IL-1-receptor-antagonist in multisystem inflammatory syndrome in children

K. Roemer, D. Foell, S. Lohse, 2021, medRxiv.

Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients

W. Wilmanns, R. Issels, W. Simon, 2005, Journal of Cancer Research and Clinical Oncology.

Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study.

W. Wilmanns, R. Issels, K. Jauch, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.

R. Issels, K. Jauch, S. Abdel-Rahman, 1993, Cancer chemotherapy and pharmacology.

Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.

W Hiddemann, U. Aydemir, W. Hiddemann, 2001, European journal of cancer.

Regional hyperthermia combined with systemic chemotherapy in advanced abdominal and pelvic tumors: first results of a pilot study employing an annular phased array applicator.

W. Wilmanns, R. Issels, M. Wadepohl, 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Treatment of refractory severe aplastic anemia with granulocyte colony stimulating factor and interleukin 3

W. Wilmanns, C. Thomssen, H. Sauer, 1994, American journal of hematology/oncology.